好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effect on Verbal (Phonemic) Fluency and Patient Satisfaction in Chronic Migraine Patients Converted from Immediate-Release Topiramate (TPM-IR) to Extended-Release Topiramate (Trokendi XR®)
Headache
P2 - (-)
176
Authors/Disclosures
John F. Rothrock, MD (Inova Health)
PRESENTER 		Dr. Rothrock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Rothrock has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Dr. Rothrock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. The institution of Dr. Rothrock has received research support from AbbVie. The institution of Dr. Rothrock has received research support from Ipsen. The institution of Dr. Rothrock has received research support from Lundbeck.
Amanda Tinsley, MD No disclosure on file
Diane A. Andress-Rothrock (UAB - Neurolgy) No disclosure on file